Skip to main content
. 2009 Feb;4(2):345–353. doi: 10.2215/CJN.02070508

Table 5.

Incidence of cyclosporine use and dose by renal pathology in allogeneic transplant recipients (n = 196)

Pathology finding n Any CSA (n, %) Median cumulative dose (mg) Median dose per day (mg)a
Negative 144 133 (92) 4706 161
TMA 55 53 (96) 13990 176
Isolated 40 38 (95) 6975 174
a

Calculated as the cumulative dose divided by number of days alive post-transplant.